Contact

Explore the opportunity

Interested in acquiring Omnicin Therapeutics or exploring an exclusive licensing opportunity for Bismocin?

We welcome enquiries from pharmaceutical companies, strategic investors and potential development partners. Contact us to discuss the opportunity or request further information.